Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
IRulya Therapeutics Inc.
Thye Dirk, an insider at IRulya Therapeutics Inc., has filed a Form 144 to report a proposed sale of company securities. This filing serves as a formal notification of the insider's plan to dispose of their holdings.…more
IRulya Therapeutics Inc.
Catherine M. Bonuccelli, an officer or major shareholder of IRulya Therapeutics Inc., has executed a power of attorney for the filing of SEC Forms 3, 4, and 5. This document appoints Brigette Roberts and John Militello as attorneys-in-fact to fulfill reporting obligations under Section 16(a) of the Securities Exchange Act.…more
IRulya Therapeutics Inc.
James Elwood Valentine of IRulya Therapeutics Inc. has executed a power of attorney authorizing designated company representatives to file Forms 3, 4, and 5 with the SEC. This action facilitates compliance with reporting requirements under Section 16(a) of the Securities Exchange Act for officers, directors, or beneficial owners.…more
7 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
No news collected yet. New articles will appear here.